Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer

See Locations Near You

Summary

Phase 1 study to evaluate the safety and effect of Gedatolisib and PTK7-ADC for the treatment of triple negative breast cancer

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Metastatic Triple-negative Breast Cancer
Willingness to undergo tumor biopsy
Patients must have received at least 1 prior chemotherapy regimen for metastatic disease

Exclusion Criteria:

Previous treatment with mTOR inhibitor
Untreated brain metastases

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

18

Study ID:

NCT03243331

Recruitment Status:

Completed

Sponsor:

Kathy Miller

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

IU Simon Cancer Center
Indianapolis Indiana, 46202, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

18

Study ID:

NCT03243331

Recruitment Status:

Completed

Sponsor:


Kathy Miller

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider